The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma
2 مناظر
• 07/18/23
0
0
ایمبیڈ
administrator
سبسکرائبرز
Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) and its long-term potential in the field of sarcoma.
مزید دکھائیں
فیس بک کے تبصرے
SORT BY-
سرفہرست تبصرے
-
تازہ ترین تبصرے